Guided Therapeutics (GTHP) Cash & Equivalents (QoQ) (2011 - 2025)
Guided Therapeutics (GTHP) Cash & Equivalents (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.59% |
| Sep 30, 2025 | -52.97% |
| Jun 30, 2025 | 60.87% |
| Mar 31, 2025 | -70.36% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | -29.45% |
| Jun 30, 2024 | -38.20% |
| Mar 31, 2024 | -24.70% |
| Dec 31, 2023 | -19.15% |
| Sep 30, 2023 | -46.17% |
| Jun 30, 2023 | -26.08% |
| Mar 31, 2023 | -20.58% |
| Dec 31, 2022 | -14.24% |
| Sep 30, 2022 | 504.71% |
| Jun 30, 2022 | -38.48% |
| Mar 31, 2022 | 12.75% |
| Dec 31, 2021 | 18.85% |
| Sep 30, 2021 | -41.32% |
| Jun 30, 2021 | -26.06% |
| Mar 31, 2021 | 585.16% |